U.S. health regulators said Monday they had licensed a new treatment for multidrug-resistant tuberculosis — the first such federal approval aimed at tackling the deadly disease in 40 years. The Food and Drug Administration (FDA) said it was approving the drug, named Sirturo, as an alternative…
Link:
U.S. regulators approve new tuberculosis drug
Print 
PDF
